Aarti Pharmalabs Q4 Results
- BSE: 543748
- NSE: AARTIPHARM
- ISIN: INE0LRU01027
- Sector: Biotechnology & Drugs
BSE
829
-0.75 (-0.09%)
-0.75 (-0.09%)Volume15.11 K
Updated: Thu 10 Sep, 2026 | 15:29:04
NSE
825.75-3.90 (-0.47%)
-3.90 (-0.47%)Volume2.85 L
Updated: Thu 10 Sep, 2026 | 15:31:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Aarti Pharmalabs Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 480.68 | 361.38 | 33.01% | 407.38 | 9.01% |
| Depreciation/ Amortization | 28.16 | 28.62 | -1.61% | 19.13 | 23.41% |
| Operating Income | 101.97 | 70.90 | 43.82% | 98.39 | -16.97% |
| Net Income | 49.30 | 47.96 | 2.80% | 65.25 | -44.19% |
| Other Operating Expenses Total | 124.45 | 113.93 | 9.24% | 0.00 | 0.00% |
| Net Income Before Taxes | 65.88 | 62.87 | 4.79% | 95.75 | -42.52% |
| Total Revenue | 582.64 | 432.27 | 34.79% | 505.77 | 3.35% |
| Selling/ General/ Admin Expenses Total | 45.05 | 43.38 | 3.85% | 135.14 | -67.69% |
| Diluted Normalized EPS | 5.26 | 5.53 | -4.78% | 7.20 | -46.03% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.